A recent congressional subcommittee hearing led by Rep. Nancy Mace scrutinized over $10 million in taxpayer-funded experiments on transgender animals, raising questions about their ethical and scientific value.

The controversial investigation revealed funding for studies involving transgender mice, rats, and monkeys to explore fertility and hormone impacts, among other factors, The Christian Post reported.

The inquiry into these taxpayer-funded experiments was spearheaded by the White Coat Waste Project, a nonprofit watchdog focusing on government spending on animal testing. This project has highlighted concerns about both the necessity and humanity of such research.

The hearing, evocatively titled "Transgender Lab Rats and Poisoned Puppies: Oversight of Taxpayer-Funded Animal Cruelty," brought to light several specific studies that used a substantial amount of public funds. Rep. Nancy Mace took a firm stand against these experiments, which she argued reflect poorly on the administration's priorities concerning scientific research and animal welfare.

One of the scrutinized studies involved transgender mice, with $2.5 million allocated to investigate their fertility. This particular research aimed to understand how changes in gender identity induced by hormones might affect reproductive capabilities.

Substantial Funding Goes to Testing on Rats and Monkeys

Another notable expenditure was $1.1 million, used to study the effects of testosterone therapy on female rats. This study was intended to mimic the hormone replacement therapy that transgender men undergo and to observe potential overdoses of a chemsex drug commonly used in some communities.

In addition to these rodent experiments, primate research was also conducted. Male monkeys were subjected to hormone treatments to test if these alterations increased their susceptibility to HIV. Rep. Mace criticized this particular study for its flawed premise, noting the known fact that "monkeys cannot be infected with HIV."

During the hearing, Justin Goodman from the White Coat Waste Project highlighted the broader issues of animal testing within the U.S. government's research funding. He stated that the government is a major global funder of such experiments, with a particular emphasis on studies that might not directly translate to human health benefits.

Debate Over Ethical and Financial Concerns

Goodman reported an overwhelming percentage of funding for these animal studies comes from Dr. Anthony Fauci's National Institute for Allergy and Infectious Diseases. He indicated that around 95% of the NIH funding allocated to studying the effects of sex party drugs and hormonal impacts on lab animals stemmed from this institute.

Alongside the ethical concerns, financial implications were also a major point of discussion. The White Coat Waste Project estimates that the U.S. wastes over $20 billion annually on animal testing, which they claim often fails to yield relevant data for human health due to biological differences between species.

The same federal agency behind these controversial studies also funded initiatives to make biology courses more inclusive for trans-identifying students. Last year, nearly $1 million was directed towards three academic institutions to adapt course content to better acknowledge the non-binary nature of sex and gender.

Reactions and Future Implications of Funding Decisions

Rep. Nancy Mace vehemently opposed the Biden-Harris Administration’s approach, stating, “The Biden-Harris Administration was so eager to propagate their radical gender ideology across all facets of American society that they did not pause to consider that such experiments are not only cruel but unnecessary.”

This sentiment was echoed by many during the hearing, questioning the justification for using vast sums of taxpayer money on projects with questionable relevance and efficacy. The hearing aimed not only to highlight these financial and ethical issues but also to push for greater oversight and reconsideration of future funding in similar research areas.

The discussions and testimonies during this subcommittee hearing have opened the floor to a broader debate on the practices of funding animal research and its implications for both taxpayer spending and animal welfare. As this story develops, further scrutiny and legislative measures could be on the horizon to address these contentious issues.